Although the patent on valsartan (Diovan, Novartis) expired last Friday, a generic version of the popular antihypertensive drug has yet to make it to market. By contrast, a generic version of Diovan ...
The Food and Drug Administration (FDA) has expanded the approval of Diovan (valsartan) to include patients 1 to 5 years of age for the treatment of hypertension. Previously, the treatment was ...
The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Valsartan (Diovan (160 mg)) is an angiotensin II ...
Diovan HCT is used for the treatment of high blood pressure (:HBP). According to IMS Health, Diovan HCT (80/12.5 mg, 160/12.5 mg, 160/25 mg, 320/12.5 mg and 320/25 mg tablets), generated US revenues ...
Both the active pharmaceutical (API) and the formulation plants in India that Ranbaxy Laboratories planned to use to manufacture the long-delayed generic of Novartis ...
The long-delayed and highly anticipated launch of generic Diovan is on the way, which is a bummer for Novartis ($NVS) and a huge boost for Indian drugmaker Ranbaxy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results